The ongoing corporate battle to hold down health plan increases should show some results next year. But prescription drugs continue to foil attempts to truly rein in health care costs.

That is the main finding in a new health plan cost trend survey from benefits and HR consulting firm The Segal Group. It's the 18th edition of the trend survey, and Segal made no bones about the concerns raised by the trending of drug prices.

"New specialty drugs coming onto the market and price increases for brand-name drugs are the main forces driving prescription drug plan cost trends," said Edward Kaplan, Segal's national health practice leader. "Typically, less than one percent of all prescriptions are specialty drug medications, yet these drugs now account for more than 25 percent of total prescription drug cost trends. The projected specialty drug/biotech trend rate for 2015 is an exceptionally high 19.4 percent."

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events
  • Access to other award-winning ALM websites including and

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Dan Cook

Dan Cook is a journalist and communications consultant based in Portland, OR. During his journalism career he has been a reporter and editor for a variety of media companies, including American Lawyer Media, BusinessWeek, Newhouse Newspapers, Knight-Ridder, Time Inc., and Reuters. He specializes in health care and insurance related coverage for BenefitsPRO.